Cidara Therapeutics Files 8-K Report
| Field | Detail |
|---|---|
| Company | Cidara Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-update
Related Tickers: CDTX
TL;DR
CDTX filed an 8-K on 6/23/25, check for updates.
AI Summary
On June 23, 2025, Cidara Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant business occurrences. No specific monetary transactions or new partnerships were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals to investors and the market that Cidara Therapeutics has made a regulatory submission, potentially containing material updates about the company's operations or financial health.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification without specific financial or operational disclosures that would indicate immediate risk.
Key Players & Entities
- Cidara Therapeutics, Inc. (company) — Registrant
- K2 Therapeutics, Inc. (company) — Former Company Name
- June 23, 2025 (date) — Date of Report
- 6310 Nancy Ridge Drive, Suite 101 San Diego, California 92121 (address) — Principal Executive Offices
- 858-752-6170 (phone_number) — Principal Executive Offices Phone Number
FAQ
What is the primary purpose of this 8-K filing for Cidara Therapeutics?
The filing is primarily for "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant business occurrences.
When was this 8-K report filed?
The report was filed on June 23, 2025.
What was Cidara Therapeutics' former company name?
Cidara Therapeutics, Inc. was formerly known as K2 Therapeutics, Inc.
Where are Cidara Therapeutics' principal executive offices located?
The principal executive offices are located at 6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121.
What is the telephone number for Cidara Therapeutics' principal executive offices?
The telephone number is (858) 752-6170.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Cidara Therapeutics, Inc..